ETC-1002 Rapidly and Significantly Reduces LDL-Cholesterol and is Well Tolerated in Healthy Subjects†
Journal of clinical lipidology(2013)
摘要
Dr. Rosenberg is employed by Esperion Therapeutics.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要